|
|
|
Volumn 18 Suppl A, Issue , 2002, Pages
|
|
Angiotensin blockade in type 2 diabetes: what the new evidence tells us about renal and cardiac complications.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMLODIPINE;
ANGIOTENSIN RECEPTOR;
ANTIHYPERTENSIVE AGENT;
BIPHENYL DERIVATIVE;
CALCIUM CHANNEL BLOCKING AGENT;
CAPTOPRIL;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
IRBESARTAN;
LOSARTAN;
RAMIPRIL;
TETRAZOLE DERIVATIVE;
ALBUMINURIA;
CARDIOVASCULAR DISEASE;
CLINICAL TRIAL;
DIABETES MELLITUS;
DIABETIC ANGIOPATHY;
DIABETIC NEPHROPATHY;
DRUG ANTAGONISM;
HUMAN;
KIDNEY DISEASE;
PROGNOSIS;
REVIEW;
ALBUMINURIA;
AMLODIPINE;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
ANTIHYPERTENSIVE AGENTS;
BIPHENYL COMPOUNDS;
CALCIUM CHANNEL BLOCKERS;
CAPTOPRIL;
CARDIOVASCULAR DISEASES;
CLINICAL TRIALS;
DIABETES COMPLICATIONS;
DIABETES MELLITUS;
DIABETIC ANGIOPATHIES;
DIABETIC NEPHROPATHIES;
HUMANS;
KIDNEY DISEASES;
LOSARTAN;
PROGNOSIS;
RAMIPRIL;
RECEPTORS, ANGIOTENSIN;
TETRAZOLES;
|
|
EID: 0036580632
PISSN: 0828282X
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (2)
|
|
References (11)
|
